Cornell University researchers and collaborators have developed a neural implant so small that it can rest on a grain of salt ...

Phase 3 PEAK results in 2nd-line GIST patients expected in November; pivotal APEX results in AdvSM patients expected in ...

While fall is the season that mums pop up in garden shops, there's a better alternative: bright, colorful ornamental cabbage, ...

At the iGEM competition in Paris, high school and collegiate teams from around the world compete against one another with ...

Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the company will present updated safety and efficacy ...

To truly deliver on their promise, nitrogen-fixing microbes need to up their game, says Ginkgo ag bio head, Michael Miile.

Scientists at UC San Diego’s Scripps Institution of Oceanography have described a new way to produce large amounts of xanthommatin, a natural pigment, in a bacterium for the first time. Xanthommatin ...

There is, however, a genetically engineered pig kidney ... but I'm just not sure then why every single application has to ...

Duchenne (SGT-003): 23 participants have been dosed in the INSPIRE DUCHENNE trial as of October 31, 2025; Solid expects to ...

Phase 3 PEAK results in 2nd-line GIST patients expected in November; pivotal APEX results in AdvSM patients expected in December Breakthrough Therapy Designation granted for bezuclastinib; New Drug Ap ...

Cornell researchers and collaborators have developed a neural implant so small that it can rest on a grain of salt, yet it ...

Ongoing Phase 1 APOLLO study investigating MT-601 in patients with relapsed B cell lymphomas showed encouraging preliminary efficacy data ...